Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Invivoscribe Appoints Masato Sasaki as General Manager of LabPMM, GK (Japan) 2023-02-02 05:00
HanAll Biopharma Reports Full-Year 2022 Results and Provides Business Update 2023-02-01 20:00
Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers 2023-02-01 15:00
CARsgen Announces Collaboration Agreement to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer 2023-01-31 21:50
Global Times: 'So much better than we had anticipated': China's rural regions embrace Spring Festival as COVID peak ebbs away 2023-01-31 21:41
Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short 2023-01-31 21:30
Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China 2023-01-31 20:30
Appendix 4C - Q2 FY23 Quarterly Cash Flow Report 2023-01-31 20:25
Ascletis Announces U.S. FDA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection 2023-01-31 17:40
Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic 2023-01-31 16:10
Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic Pulmonary Fibrosis in the Greater China Region 2023-01-31 14:43
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology 2023-01-31 09:24
Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of Type 2 Diabetes in China 2023-01-31 08:00
Help Therapeutics Announces IND Approval of First Universal iPSC-derived Cardiomyocyte Therapy for End-stage Heart Failure in China 2023-01-30 23:00
Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer 2023-01-30 20:39
Kalbe Consumer Health Crowned Winner at the Asia Pacific Enterprise Awards 2022 Regional Edition 2023-01-30 11:26
Abbisko Therapeutics announces that US FDA has granted breakthrough therapy designation for its CSF-1R inhibitor Pimicotinib（ABSK021） 2023-01-30 11:00
Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases 2023-01-30 10:00
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results 2023-01-27 14:52
Malaysian Society of Plastic and Reconstructive Surgery to host extensive networking and learning event for plastic surgeons and residents 2023-01-27 08:00
1 89 90 91 92 93 377